News

The US Department of Health and Human Services (HSS) has terminated a contract previously awarded to Moderna to help advance a vaccine candidate targeting avian influenza, more commonly known as ...
Shares of Moderna were flat in after-market trading. Moderna in January was awarded US$590 million by the Biden administration to advance the development of its bird flu vaccine, and support the ...
Moderna in January was awarded $590 million by the Biden administration to advance the development of its bird flu vaccine, and support the expansion of clinical studies for up to five additional ...
The Trump administration has cancelled a contract awarded to Moderna for the late-stage development of its bird flu vaccine for humans, as well as the right to purchase shots, according to the ...
In January, Moderna was awarded $590 million by the Biden administration to advance the development of its bird flu vaccine, and support the expansion of clinical studies for up to five additional ...
U.S. Senate Democrats demanded on Wednesday Health Secretary Robert F. Kennedy Jr. make public the reviews on which his department said it based its decision to cancel a contract for developing a ...
US President Donald Trump's administration on Wednesday canceled a $590 million contract with Moderna to develop an avian flu vaccine, the US biotech company said.
The Trump administration has terminated a multi-million-dollar contract with Massachusetts-based Moderna to support its late-stage development of a bird flu vaccine for humans. The company ...
The H5N1 bird flu has been spreading widely among wild birds, poultry and other animals around the world for several years, and starting early last year became a problem in people and cows in the U.S.
The Department of Health and Human Services is ending a $766 million contract with the vaccine company Moderna to develop an mRNA vaccine for flu strains with pandemic potential, including bird flu.
Moderna in January was awarded $590 million by the Biden administration to advance the development of its bird flu vaccine, and support the expansion of clinical studies for up to five additional ...
Moderna in January was awarded $590 million by the Biden administration to advance the development of its bird flu vaccine, and support the expansion of clinical studies for up to five additional ...